Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

No matter how hard ideologues try to exclusively blame their political foes for acts of political violence, the truth is that violent extremists today emerge from across the political spectrum. We ...

Because there’s a silver lining for most things in life, maybe there’s also one for ABC’s craven (if brief) suspension, under thuggish government pressure, of Jimmy Kimmel’s late-night talk show. To ...

Democrats and members of the corporate media have repeatedly claimed that the fatal shooting of Turning Point USA founder Charlie Kirk was not celebrated, but online history tells a different story.

Do you know what it means to "drive left of center"? No matter if it pops up in a driver's ed class, an accident report, or a traffic stop, it's a phrase drivers need to be familiar with. Put simply, ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...